Literature DB >> 25762721

Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.

Corina Russwurm1, Doris Koesling1, Michael Russwurm2.   

Abstract

Phosphodiesterase 10A (PDE10A) is a dual substrate PDE that can hydrolyze both cGMP and cAMP. In brain, PDE10A is almost exclusively expressed in the striatum. In several studies, PDE10A has been implicated in regulation of striatal output using either specific inhibitors or PDE10A knock-out mice and has been suggested as a promising target for novel antipsychotic drugs. In striatal medium spiny neurons, PDE10A is localized at the plasma membrane and in dendritic spines close to postsynaptic densities. In the present study, we identify PDE10A as the major cAMP PDE in mouse striatum and monitor PKA-dependent PDE10A phosphorylation. With recombinantly expressed PDE10A we demonstrate that phosphorylation does not alter PDE10A activity. In striatum, PDE10A was found to be associated with the A kinase anchoring protein AKAP150 suggesting the existence of a multiprotein signaling complex localizing PDE10A to a specific functional context at synaptic membranes. Furthermore, the cAMP effector PKA, the NMDA receptor subunits NR2A and -B, as well as PSD95, were tethered to the complex. In agreement, PDE10A was almost exclusively found in multiprotein complexes as indicated by migration in high molecular weight fractions in size exclusion chromatography. Finally, affinity of PDE10A to the signaling complexes formed around AKAP150 was reduced by PDE10A phosphorylation. The data indicate that phosphorylation of PDE10 has an impact on the interaction with other signaling proteins and adds an additional line of complexity to the role of PDE10 in regulation of synaptic transmission.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  A-kinase Anchoring Protein (AKAP); Cell Signaling; Cyclic AMP (cAMP); Phosphodiesterases; Protein Complex; Protein Kinase A (PKA)

Mesh:

Substances:

Year:  2015        PMID: 25762721      PMCID: PMC4424333          DOI: 10.1074/jbc.M114.595769

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Networking with AKAPs: context-dependent regulation of anchored enzymes.

Authors:  Emily J Welch; Brian W Jones; John D Scott
Journal:  Mol Interv       Date:  2010-04

2.  Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons.

Authors:  David T S Lin; Pascale Fretier; Cindy Jiang; Steven R Vincent
Journal:  Synapse       Date:  2010-06       Impact factor: 2.562

3.  Association of protein kinase A and protein phosphatase 2B with a common anchoring protein.

Authors:  V M Coghlan; B A Perrino; M Howard; L K Langeberg; J B Hicks; W M Gallatin; J D Scott
Journal:  Science       Date:  1995-01-06       Impact factor: 47.728

4.  Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart.

Authors:  P Han; X Zhu; T Michaeli
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

5.  ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.

Authors:  T A Wyatt; A J Naftilan; S H Francis; J D Corbin
Journal:  Am J Physiol       Date:  1998-02

6.  cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity.

Authors:  P G Grant; A F Mannarino; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting.

Authors:  H Liu; D H Maurice
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

8.  Membrane-targeting sequences on AKAP79 bind phosphatidylinositol-4, 5-bisphosphate.

Authors:  M L Dell'Acqua; M C Faux; J Thorburn; A Thorburn; J D Scott
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

9.  Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit.

Authors:  K W Roche; R J O'Brien; A L Mammen; J Bernhardt; R L Huganir
Journal:  Neuron       Date:  1996-06       Impact factor: 17.173

10.  Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.

Authors:  C Sette; M Conti
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

View more
  17 in total

1.  Cross-regulation of Phosphodiesterase 1 and Phosphodiesterase 2 Activities Controls Dopamine-mediated Striatal α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking.

Authors:  Roy S Song; Rosa Tolentino; Eric A Sobie; Susana R Neves-Zaph
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

2.  Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke.

Authors:  Mustafa C Beker; Ahmet B Caglayan; Serdar Altunay; Elif Ozbay; Nilay Ates; Taha Kelestemur; Berrak Caglayan; Ulkan Kilic; Thorsten R Doeppner; Dirk M Hermann; Ertugrul Kilic
Journal:  Mol Neurobiol       Date:  2021-11-04       Impact factor: 5.590

3.  Discovery of a highly specific 18F-labeled PET ligand for phosphodiesterase 10A enabled by novel spirocyclic iodonium ylide radiofluorination.

Authors:  Zhiwei Xiao; Huiyi Wei; Yi Xu; Ahmed Haider; Junjie Wei; Shiyu Yuan; Jian Rong; Chunyu Zhao; Guocong Li; Weibin Zhang; Huangcan Chen; Yuefeng Li; Lingling Zhang; Jiyun Sun; Shaojuan Zhang; Hai-Bin Luo; Sen Yan; Qijun Cai; Lu Hou; Chao Che; Steven H Liang; Lu Wang
Journal:  Acta Pharm Sin B       Date:  2021-11-17       Impact factor: 14.903

4.  Druggable transcriptomic pathways revealed in Parkinson's patient-derived midbrain neurons.

Authors:  Mark van den Hurk; Shong Lau; Maria C Marchetto; Jerome Mertens; Shani Stern; Olga Corti; Alexis Brice; Beate Winner; Jürgen Winkler; Fred H Gage; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2022-10-18

Review 5.  Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.

Authors:  George S Baillie; Gonzalo S Tejeda; Michy P Kelly
Journal:  Nat Rev Drug Discov       Date:  2019-08-06       Impact factor: 84.694

6.  TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.

Authors:  Kazunori Suzuki; Akina Harada; Hirobumi Suzuki; Maki Miyamoto; Haruhide Kimura
Journal:  Neuropsychopharmacology       Date:  2016-02-05       Impact factor: 7.853

7.  Selective Effects of PDE10A Inhibitors on Striatopallidal Neurons Require Phosphatase Inhibition by DARPP-32

Authors:  Marina Polito; Elvire Guiot; Giuseppe Gangarossa; Sophie Longueville; Mohamed Doulazmi; Emmanuel Valjent; Denis Hervé; Jean-Antoine Girault; Danièle Paupardin-Tritsch; Liliana R V Castro; Pierre Vincent
Journal:  eNeuro       Date:  2015-08-31

8.  De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.

Authors:  Niccolò E Mencacci; Erik-Jan Kamsteeg; Kosuke Nakashima; Lea R'Bibo; David S Lynch; Bettina Balint; Michèl A A P Willemsen; Matthew E Adams; Sarah Wiethoff; Kazunori Suzuki; Ceri H Davies; Joanne Ng; Esther Meyer; Liana Veneziano; Paola Giunti; Deborah Hughes; F Lucy Raymond; Miryam Carecchio; Giovanna Zorzi; Nardo Nardocci; Chiara Barzaghi; Barbara Garavaglia; Vincenzo Salpietro; John Hardy; Alan M Pittman; Henry Houlden; Manju A Kurian; Haruhide Kimura; Lisenka E L M Vissers; Nicholas W Wood; Kailash P Bhatia
Journal:  Am J Hum Genet       Date:  2016-04-07       Impact factor: 11.025

9.  A novel thermoregulatory role for PDE10A in mouse and human adipocytes.

Authors:  Mohammed K Hankir; Mathias Kranz; Thorsten Gnad; Juliane Weiner; Sally Wagner; Winnie Deuther-Conrad; Felix Bronisch; Karen Steinhoff; Julia Luthardt; Nora Klöting; Swen Hesse; John P Seibyl; Osama Sabri; John T Heiker; Matthias Blüher; Alexander Pfeifer; Peter Brust; Wiebke K Fenske
Journal:  EMBO Mol Med       Date:  2016-07-01       Impact factor: 12.137

Review 10.  An update of cyclic nucleotide phosphodiesterase as a target for cardiac diseases.

Authors:  Si Chen; Chen Yan
Journal:  Expert Opin Drug Discov       Date:  2020-09-21       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.